Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Metadata analysis of Boehringer Ingelheim's opnMe database reveals the potential of BI-1942, a chymase inhibitor, for ophthalmic indications repurposing

Abbe Pingol; Hovhannes J Gukasyan; Marcus Terneus; Jessica Bramhall; Sammy Bell

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6126.

ARVO Annual Meeting Abstract June 2024

In silico simulation models for preclinical pharmacokinetic profiling in drug repositioning of a cathepsin S inhibitor for age-related dry eye

Bruno Baltazar; Marcus Terneus; Jessica Bramhall; Sammy Bell; Hovhannes J Gukasyan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6124.

ARVO Annual Meeting Abstract June 2024

Computational Models for Ocular Drug Repurposing of a Ribosomal S6 Kinase Inhibitor (RSKi) in Treatment of Retinal Degenerative Diseases

Lilit Mikayelyan; Marcus Terneus; Jessica Bramhall; Sammy Bell; Hovhannes J Gukasyan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6128.

ARVO Annual Meeting Abstract June 2024

Revealing the potential of Cathepsin S inhibitor, BI-1915, for ophthalmic repurposing through the metadata analysis of Boehringer Ingelheim's opnMe database

Ethan Buriel; Marcus Terneus; Jessica Bramhall; Sammy Bell; Hovhannes J Gukasyan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6127.

ARVO Annual Meeting Abstract June 2024

Utilization of computational methods for drug repositioning of a bradykinin 1 receptor antagonist in ocular posterior segment diseases

Tiffany Yarian; Marcus Terneus; Jessica Bramhall; Sammy Bell; Hovhannes J Gukasyan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6125.

Advertisement